You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Details for Patent: 10,933,053


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,933,053 protect, and when does it expire?

Patent 10,933,053 protects ZERBAXA and is included in one NDA.

This patent has seven patent family members in four countries.

Summary for Patent: 10,933,053
Title:Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
Abstract: Disclosed are methods of administering cephalosporin/tazobactam to human patients with end stage renal disease undergoing hemodialysis and suffering from a complicated intra-abdominal infection or a complicated urinary tract infection.
Inventor(s): Krishna; Gopal (Stow, MA), Chandorkar; Gurudatt (Waltham, MA), Hershberger; Elham (Lexington, MA), Miller; Benjamin (Cambridge, MA), Xiao; Alan (Lexington, MA)
Assignee: MERCK SHARP & DOHME CORP. (Rahway, NJ)
Application Number:16/525,458
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,933,053

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property, particularly in highly regulated and competitive fields such as pharmaceuticals. This article will delve into the details of United States Patent 10,933,053, examining its claims, scope, and the broader patent landscape it inhabits.

Overview of the Patent

United States Patent 10,933,053 is a patent that covers specific innovations within the pharmaceutical industry. To analyze this patent, it is essential to understand the context in which it was granted and the specific claims it makes.

Claims of the Patent

Claim Structure

Patent claims are the heart of any patent application, defining the scope of protection granted by the patent. For Patent 10,933,053, each claim must be carefully examined to understand what is protected.

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. They are critical in determining the overall protection offered by the patent.
  • Dependent Claims: These claims build upon the independent claims and provide additional specificity, often narrowing down the scope to particular embodiments or applications of the invention.

Claim Analysis

To analyze the claims of Patent 10,933,053, one must consider the following:

  • Subject Matter: What specific subject matter does the patent cover? This could include chemical compounds, methods of manufacture, or methods of use.
  • Scope of Protection: How broad or narrow are the claims? Do they cover a wide range of applications or are they highly specific?
  • Novelty and Non-Obviousness: Do the claims meet the criteria for novelty and non-obviousness as required by patent law?

Scope of the Patent

Technical Field

The technical field in which the patent operates is crucial for understanding its relevance and impact. For pharmaceutical patents, this often involves specific therapeutic areas, drug delivery mechanisms, or novel compounds.

Practical Applications

As highlighted in the 2024 USPTO guidance update on AI patents, demonstrating real-world applications of the claimed method or system is vital for patent eligibility[4]. For Patent 10,933,053, it is important to identify how the claimed inventions are applied in practical settings, such as in the treatment of specific diseases or conditions.

Patent Landscape

Competing Patents

The patent landscape includes all relevant patents that cover similar subject matter. Analyzing this landscape involves identifying:

  • Overlapping Claims: Are there other patents with claims that overlap or conflict with those of Patent 10,933,053?
  • Gaps in Coverage: Are there areas where the patent does not provide coverage, indicating potential opportunities for further innovation or patent filings?

Patent Analytics

Tools like Claim Coverage Matrix and Claim Charts can be invaluable in analyzing the patent landscape. These tools help categorize patents by claims and scope concepts, making it easier to identify gaps and opportunities[3].

Expiration and Generic Entry

Patent Term

Understanding the expiration date of the patent is critical for planning future strategies. The patent term can be affected by various factors, including Patent Term Adjustments (PTA) and terminal disclaimers, as seen in cases like the Cellect LLC appeal[1].

Generic Entry

The expiration of a patent can lead to generic entry, where other companies can begin manufacturing and selling the same or similar products. Monitoring the patent's expiration date and any potential extensions or adjustments is essential for both the patent holder and potential generic entrants.

Obviousness and Double Patenting

Obviousness Type Double Patenting (ODP)

ODP is a critical issue in patent law, preventing an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of PTA[1].

  • Impact on Patent Term: ODP analysis must consider the adjusted expiration date of the patent, including any PTA granted.
  • Terminal Disclaimers: These are often used to overcome ODP rejections and ensure that the patent term is not extended beyond the date of a terminal disclaimer.

Real-World Implications

Market Impact

The scope and claims of Patent 10,933,053 have significant implications for the market. For example, if the patent covers a novel compound or method of treatment, it could provide a competitive advantage to the patent holder until the patent expires.

Regulatory Compliance

Compliance with regulatory requirements is essential. The patent must align with FDA regulations and other relevant standards to ensure that the patented products or methods can be legally marketed and used.

Key Takeaways

  • Claims Analysis: Carefully review the independent and dependent claims to understand the scope of protection.
  • Practical Applications: Demonstrate real-world applications of the claimed inventions to bolster patent eligibility.
  • Patent Landscape: Use patent analytics tools to identify gaps and opportunities in the patent landscape.
  • Expiration and Generic Entry: Monitor the patent's expiration date and potential extensions or adjustments.
  • ODP and Terminal Disclaimers: Ensure compliance with ODP rules and consider terminal disclaimers to avoid patent term extensions.

FAQs

What is the significance of independent claims in a patent?

Independent claims define the broadest scope of the invention and are critical in determining the overall protection offered by the patent.

How does the USPTO guidance update on AI patents affect pharmaceutical patents?

The guidance emphasizes the importance of demonstrating real-world applications of the claimed method or system, which is also relevant for pharmaceutical patents in showing practical utility.

What is Obviousness Type Double Patenting (ODP)?

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of PTA.

How do terminal disclaimers affect the patent term?

Terminal disclaimers are used to overcome ODP rejections and ensure that the patent term is not extended beyond the date of the terminal disclaimer.

What tools can be used to analyze the patent landscape?

Tools like Claim Coverage Matrix and Claim Charts can be used to categorize patents by claims and scope concepts, helping to identify gaps and opportunities in the patent landscape.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1]
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov[2]
  3. Patent Analytics - Schwegman, Lundberg & Woessner, P.A.[3]
  4. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz[4]
  5. Pharmaceutical drugs covered by patent 10,933,053 - Drug Patent Watch[5]

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,933,053

Showing 1 to 2 of 2 entries

International Family Members for US Patent 10,933,053

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2014233637 ⤷  Try for Free
Australia 2016202199 ⤷  Try for Free
Australia 2017279686 ⤷  Try for Free
Australia 2020202756 ⤷  Try for Free
European Patent Office 3043797 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.